The Quest to End Colon Cancer
Over 150,000 Americans are diagnosed with colon cancer every year, making it one of the most common cancers. And it kills over 50,000 Americans each year, making it one of the deadliest.
Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.
The Quest to Defeat Prostate Cancer
Nearly one in eight men in the United States are diagnosed with prostate cancer in their lifetime. Every year, almost 300,000 discover that they have prostate cancer and over 30,000 die from it, making it one of the most survivable cancers and also the second highest cause of cancer death among men.
Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.
Our Quest to Combat ALS
Over 30,000 Americans are living with amyotrophic lateral sclerosis (ALS).
Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.
Our Quest to Cure Cancer
Over 2 million Americans are diagnosed with cancer each year.
Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.
Our Quest to Defeat Blood Cancer
Over 1.5 million Americans are living with blood cancers—leukemia, lymphoma, myeloma. Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.
Our Quest to Combat Lupus
More than 1.5 million Americans live with lupus. Meet some of the biotech innovators working to develop new medicines to better treat—and even cure—this disease.
Our Quest to Conquer Arthritis
More than 1 million Americans live with rheumatoid arthritis, a painful autoimmune disease that can damage joints, skin, eyes, lungs, and more. Meet some of the biotech innovators working to develop new medicines to better treat—and even cure—this disease.
Our Quest to Defeat Cystic Fibrosis
About 40,000 children and adults in the US and approximately a hundred thousand people worldwide live with cystic fibrosis or CF. Meet some of the biotech innovators working to develop new medicines to better treat—and even cure—this disease.
Our Quest to Cure Ovarian Cancer
About 20,000 American women are diagnosed with ovarian cancer each year. Meet some of the biotech innovators working to develop new medicines to better treat—and even cure—this disease.
Our Quest to End Skin Cancer
Over 3 million Americans are diagnosed with skin cancer each year. Meet some of the biotech innovators working to develop new medicines to better treat—and even cure—this disease.
Our Quest to Treat Multiple Sclerosis
Nearly a million Americans are living with multiple sclerosis. Meet some of the biotech innovators working to develop new medicines to restore health and happiness to these patients and their families.
Our Quest to Defeat Parkinson’s Disease
Nearly 1 million Americans and over 7 million people globally are living with Parkinson's disease. Meet some of the biotech innovators working to develop new medicines to restore health and happiness to these patients and their families.
The Massachusetts Paradox
The Massachusetts biotech industry leads the world in innovation and drug development. But its companies don’t have the support of its own leaders. Why?
Autoimmune Quest v1
Biomedical innovators are developing new autoimmune therapeutics - insurance reform will ensure new treatments and cures are accessible and affordable.